Several sessions and abstracts at TCT 2026 in San Diego, CA, feature NCDR registry data. Explore the presentations below to learn more about their findings and potential implications for interventional cardiovascular care.

ACC’s CathPCI Registry

1-Year Outcomes of the AGENT Drug-Coated Balloon in Clinical Practice: Results From a Medicare-Linked CathPCI Registry Analysis
Christina Lalani, MD
Saturday, Oct. 31 at 5-5:08 p.m. PT | World Connect Theater

TCT 160: Frequency and In-Hospital Outcomes of SMuRF-less Patients With STEMI Undergoing Emergency PCI: A Retrospective Analysis From the NCDR Registry
Rajesh Kumar, MBBS, FACC
Sunday, Nov. 1 at 10:50-10:56 a.m. PT | Station 7

TCT 217: Temporal Trends and Institutional Variation in Revascularization Strategies For STEMI With Multivessel Disease: Insights From the NCDR CathPCI Registry
Ayman R. Fath, MD
Sunday, Nov. 1 at 11:30-11:36 a.m. PT | Station 7

Utilization and Outcomes of PCI Using IVL in Patients With Calcified Coronary Artery Lesions: Results From the ACC NCDR CathPCI Registry
Prakriti Gaba, MD
Sunday, Nov. 1 at 12:30-12:38 p.m. PT | Coronary Live Case Theater

TCT 550: Translating the DanGer Shock Trial to US Practice: A Transportability Analysis in the CathPCI Registry
Christina Lalani, MD
Sunday, Nov. 1 at 5:40-5:46 p.m. PT | Station 3

ACC’s LAAO Registry

TCT 1468: Severity Weighted Outcomes After LAAO in Advanced HF: A Win Ratio Analysis of a Multisite LAAO Registry
Abhinav Singh, MD, DO
Tuesday, Nov. 3 at 1-1:06 p.m. PT | Station 1

STS/ACC TVT Registry

Diagnosis-to-Valve Treatment Time in Patients With Severe AS
Kimberley Hemelrijk, BM, MD
Saturday, Oct. 31 at 8:30-8:38 a.m. | World Connect Theatre

1-Year Outcomes of TTVR With the EVOQUE System For Severe TR: Results From the STS/ACC TVT Registry
Raj R. Makkar, MD, FACC
Saturday, Oct. 31 at 10:45-10:53 a.m. PT | World Connect Theater

Impact of Baseline MV Area and Gradient on 1-Year Outcomes of M-TEER With the Pascal System in Degenerative MR: Results From the STS/ACC TVT Registry
D. Scott Lim, MD
Saturday, Oct. 31 at 11-11:08 a.m. PT | World Connect Theater

3R Session 3: Heart & Valve Collaboratory: Critical Appraisal of the Proposed TAVR NCD Update: The Heart Team, TVT, Reimbursement For CED
Roxana Mehran, MD, FACC; Sreekanth Vemulapalli, MD; et al.
Sunday, Nov. 1 at 10:45 a.m. - 12:15 p.m. PT | 3R Theater

TCT 283: Impact of Procedural Volume on 30-Day Outcomes Following T-TEER With the TriClip System: Findings From the STS/ACC TVT Registry
Brian K. Whisenant, MD, FACC
Sunday, Nov. 1 at 12:30-12:36 p.m. PT | Station 8

TCT 672: 5-Year Outcomes From the COAPT Post-Approval Study: Insights From the TVT Registry and CMS Claims Database
Andrew Morse, MD
Monday, Nov. 2 at 9:10-9:16 a.m. PT | Station 5

TCT 1522: Outcomes of M-TEER For Recurrent MR After Prior Surgical MV Repair: Insights From the STS/ACC TVT Registry
Joe Aoun, MD
Monday, Nov. 2 at 12:20-12:26 p.m. PT | Station 3

TCT 935: Antithrombotic Therapy and 1-Year Outcomes After TAV-in-TAV TAVR Procedures: Insights From the STS/ACC TVT Registry
Mahesh V. Madhavan, MD, MS
Monday, Nov. 2 at 1:40-1:46 p.m. PT | Station 10

TCT 1352: Beyond the Valve: Socioeconomic Distress, Hospital Context and Outcomes After TAVR: Insights From the TVT Registry
Dharam J. Kumbhani, MD, SM, FACC
Tuesday, Nov. 3 at 11:40-11:46 a.m. PT | Station 1

TCT 1423: 1-Year Outcomes Following TAVR With a Self-Expandable TAV With Intra-Annular Leaflet Position: Real-World Data From the STS/ACC TVT Registry
Amber Makani, MD
Tuesday, Nov. 3 at 12:30-12:36 p.m. PT | Station 3

Check out additional news from TCT 2026 on ACC’s meeting coverage page and social media.

Keywords: Transcatheter Cardiovascular Therapeutics, TCT26